Aws K. Abushanab
Zarqa, AZ, Jordan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety profile of dual TIGIT and PD-L1 blockade with tiragolumab plus atezolizumab in solid tumors: a systematic review and meta-analysis of randomized controlled trials.
Journal: Expert opinion on drug safety
Published: July 14, 2026
Safety and efficacy of spleen tyrosine kinase (Syk) inhibitors in the treatment of adults with persistent and chronic immune thrombocytopenia (ITP): A systematic review and meta-analysis of randomised clinical trials.
Journal: British journal of haematology
Published: November 01, 2025
Safety of alisertib in the treatment of solid and hematological cancers: A systematic review and meta-analysis of randomized controlled trials.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: August 26, 2025
Efficacy and safety of entinostat plus exemestane in hormone receptor-positive breast cancer: a systematic review meta-analysis of randomized controlled trials.
Journal: Breast cancer research and treatment
Published: March 06, 2025
Immune checkpoint inhibitors plus taxane-based chemotherapy for patients with advanced/metastatic NSCLC: a systematic review and meta-analysis across different PD-L1 expression levels.
Journal: Expert review of anticancer therapy
Published: January 28, 2025
Safety and efficacy of Rucaparib in the treatment of ovarian cancer and patients with BRCA mutation: a systematic review and meta-analysis of phase III randomized clinical trials.
Journal: Expert review of anticancer therapy
Published: January 22, 2024
Efficacy and safety of tislelizumab for malignant solid tumor: a systematic review and meta-analysis of phase III randomized trials.
Journal: Expert review of clinical pharmacology
Published: October 21, 2023
The efficacy and safety of Capivasertib (AZD5363) in the treatment of patients with solid tumor: a systematic review and meta-analysis of randomized clinical trials.
Journal: Expert opinion on drug safety
Published: May 24, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026